Profile banner
Andrea Mazzocchi

Andrea Mazzocchi

Scientist, entrepreneur in women's health and precision medicine

Boulder, CO
nitter+1
Joined February 2026
Favicon imagex.com
Favicon imagelinkedin.com
Favicon imagescholar.google.com
Favicon imagemedium.com
Favicon imageknownmed.com
Favicon imageaiche.org
Favicon imageworldstemcellsummit.com

Network

1.5K connections
📊
Biotech Product Ops
🧬
AI ML in Biotech
🌱
Regenerative Medicine Researchers
🎓
Wake Forest Affiliates
🔧
Biomedical Engineers
⚕️
Clinical Medical Professionals
🤖
Pathos AI Team

Summary

Andrea Mazzocchi is a serial entrepreneur with a strong background in biotechnology and AI-driven health solutions. She has co-founded two Y Combinator-backed companies: Known Medicine, an oncology diagnostics company acquired by Pathos AI, and currently Play Health, a perimenopause care platform. Her entrepreneurial journey demonstrates a consistent focus on addressing significant healthcare challenges through innovative technological approaches. nitter+4
Dr. Mazzocchi possesses deep expertise in biomedical engineering, specifically in cancer biology, tissue engineering, biomaterials, and 3D bioprinting. Her academic and research career at institutions like Wake Forest Institute for Regenerative Medicine focused on developing patient-specific models for drug screening and precision medicine, leading to numerous publications and a strong citation record on Google Scholar (h-index 13, i10-index 15 with 1558 citations). google+3
She is a passionate advocate for women's health, particularly in the underserved area of perimenopause care. At Play Health, she is pioneering a data-driven approach to help women understand and manage their symptoms by integrating at-home hormone testing, symptom tracking, and personalized insights, with the ambition of building the most comprehensive dataset on perimenopause. nitter+2
Andrea Mazzocchi has a diverse professional background, including roles in consulting, advisory positions at other biotech startups (Eris Biotech, Whelix), and experience in partnerships within the health technology sector. This breadth of experience complements her scientific and entrepreneurial ventures.

Work

Education

Writing

3D bioprinting for high-throughput screening: Drug screening, disease modeling, and precision medicine applications

January 1, 2019

A review of the applications of 3D bioprinting in drug discovery, disease modeling, and personalized medicine.

Favicon imagescholar.google.com

Model of patient-specific immune-enhanced organoids for immunotherapy screening: feasibility study

January 1, 2019

Investigated the feasibility of using patient-specific organoid models enhanced with immune components for screening immunotherapies.

Favicon imagescholar.google.com

Optimization of collagen type I-hyaluronan hybrid bioink for 3D bioprinted liver microenvironments

January 1, 2018

Research on optimizing bioink for 3D bioprinting applications, specifically for liver microenvironments.

Favicon imagescholar.google.com

In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening

January 1, 2018

Developed patient-derived 3D tumor organoids for mesothelioma to facilitate patient-specific therapeutic screening.

Favicon imagescholar.google.com

Porous membranes promote endothelial differentiation of adipose-derived stem cells and perivascular interactions

January 1, 2014

Research on how porous membranes can influence the differentiation of adipose-derived stem cells and their interactions with blood vessels.

Favicon imagescholar.google.com

Known Medicine — 2021 Year in Review

A blog post summarizing the progress and achievements of Known Medicine in 2021.

Favicon imagemedium.com

Hobbies

Enjoys flying and is a pilot. nitter

Participates in endurance athletic activities. nitter